Anne Lesoin

2.3k total citations
40 papers, 522 citations indexed

About

Anne Lesoin is a scholar working on Reproductive Medicine, Obstetrics and Gynecology and Surgery. According to data from OpenAlex, Anne Lesoin has authored 40 papers receiving a total of 522 indexed citations (citations by other indexed papers that have themselves been cited), including 28 papers in Reproductive Medicine, 13 papers in Obstetrics and Gynecology and 12 papers in Surgery. Recurrent topics in Anne Lesoin's work include Ovarian cancer diagnosis and treatment (27 papers), Endometrial and Cervical Cancer Treatments (13 papers) and Intraperitoneal and Appendiceal Malignancies (7 papers). Anne Lesoin is often cited by papers focused on Ovarian cancer diagnosis and treatment (27 papers), Endometrial and Cervical Cancer Treatments (13 papers) and Intraperitoneal and Appendiceal Malignancies (7 papers). Anne Lesoin collaborates with scholars based in France, United States and Spain. Anne Lesoin's co-authors include Éric Leblanc, S. Taïeb, Fabrice Narducci, Denis Querleu, B. Castelain, M.C. Baranzelli, Charles Fournier, Michael Frumovitz, Paul Cottu and Anne Floquet and has published in prestigious journals such as Journal of Clinical Oncology, PLoS ONE and Annals of the New York Academy of Sciences.

In The Last Decade

Anne Lesoin

40 papers receiving 509 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Anne Lesoin France	9	301	242	181	134	97	40	522
Stacy Nerenstone United States	7	281 0.9×	188 0.8×	237 1.3×	122 0.9×	76 0.8×	9	589
Hidetaka Nomura Japan	13	314 1.0×	399 1.6×	158 0.9×	104 0.8×	109 1.1×	78	625
Rosanna Mancari Italy	16	356 1.2×	234 1.0×	115 0.6×	194 1.4×	51 0.5×	33	619
Kohei Omatsu Japan	13	248 0.8×	337 1.4×	126 0.7×	123 0.9×	82 0.8×	61	561
María Jesús Rubio Spain	16	506 1.7×	214 0.9×	344 1.9×	180 1.3×	44 0.5×	48	693
Brett Winter‐Roach United Kingdom	13	490 1.6×	299 1.2×	324 1.8×	193 1.4×	45 0.5×	32	712
Eisuke Kaneki Japan	13	249 0.8×	405 1.7×	117 0.6×	89 0.7×	149 1.5×	30	624
Yevgeniy Karamurzin United States	9	129 0.4×	251 1.0×	152 0.8×	105 0.8×	173 1.8×	10	545
Alan C. Schlaerth United States	7	465 1.5×	407 1.7×	136 0.8×	112 0.8×	64 0.7×	7	659
Claudio Guerrieri United States	13	263 0.9×	128 0.5×	214 1.2×	68 0.5×	84 0.9×	31	527

Countries citing papers authored by Anne Lesoin

Since Specialization

Citations

This map shows the geographic impact of Anne Lesoin's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Anne Lesoin with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Anne Lesoin more than expected).

Fields of papers citing papers by Anne Lesoin

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Anne Lesoin. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Anne Lesoin. The network helps show where Anne Lesoin may publish in the future.

Co-authorship network of co-authors of Anne Lesoin

This figure shows the co-authorship network connecting the top 25 collaborators of Anne Lesoin. A scholar is included among the top collaborators of Anne Lesoin based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Anne Lesoin. Anne Lesoin is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Chiquet, Christophe, B. Chumpitazi, Isabelle Vilgrain, et al.. (2020). Prospective study of serum and aqueous humour anti‐Hsp70.1 IgG antibody levels in ocular toxoplasmosis. Parasite Immunology. 42(10). e12771–e12771. 1 indexed citations

Bataille, B., Alexandre Escande, Fabrice Narducci, et al.. (2019). Intracavitary Preoperative Brachytherapy Followed By Whertheim-Type Hysterectomy in Localized Cervical Cancer: Clinical Data and Toxicity Results from a Single Institution Experience. International Journal of Radiation Oncology*Biology*Physics. 105(1). E319–E320. 2 indexed citations

Lee, Chee Khoon, Rebecca Asher, Michael Friedländer, et al.. (2019). Development and validation of a prognostic nomogram for overall survival in patients with platinum-resistant ovarian cancer treated with chemotherapy. European Journal of Cancer. 117. 99–106. 18 indexed citations

Pannier, Diane, Antoine Adenis, Emilie Bogart, et al.. (2018). Once weekly paclitaxel associated with a fixed dose of oral metronomic cyclophosphamide: a dose-finding phase 1 trial. BMC Cancer. 18(1). 775–775. 2 indexed citations

Joly, Florence, Isabelle Ray‐Coquard, Claude El Kouri, et al.. (2018). Non-pegylated liposomal doxorubicin (NPLD, Myocet®) + carboplatin in patients with platinum sensitive ovarian cancers: A ARCAGY-GINECO phase IB-II trial. Gynecologic Oncology. 152(1). 68–75. 3 indexed citations

Pautier, Patricia, Elsa Kalbacher, Thibault De La Motte Rouge, Franck Bonnetain, & Anne Lesoin. (2017). Cancer de l’ovaire : la rechute précoce. Bulletin du Cancer. 104. S32–S38. 1 indexed citations

Brachet, Pierre-Emmanuel, Michel Fabbro, Alexandra Léary, et al.. (2017). A GINECO phase II study of Navitoclax (ABT 263) in women with platinum resistant/refractory recurrent ovarian cancer (ROC). Annals of Oncology. 28. v347–v347. 4 indexed citations

Rouzier, Roman, Sébastien Gouy, Frédèric Selle, et al.. (2016). Complete resection rate at interval debulking surgery after bevacizumab containing neoadjuvant therapy: primary objective of the ANTHALYA trial. Annals of Oncology. 27. vi297–vi297. 1 indexed citations

Ferron, Gwénaël, Gaëtan De Rauglaudre, Isabelle Laure Ray-Coquard, et al.. (2016). The CHIVA study: a GINECO randomized double blind phase II trial of nintedanib versus placebo with the neo-adjuvant chemotherapy (NACT) strategy for patients (pts) with advanced unresectable ovarian cancer (OC). Report of the interval debulking surgery (IDS) safety outcome. Annals of Oncology. 27. vi297–vi297. 3 indexed citations

10.

Narducci, Fabrice, et al.. (2016). Single-port or Classic Laparoscopy Compared With Laparotomy to Assess the Peritoneal Cancer Index in Primary Advanced Epithelial Ovarian Cancer. Journal of Minimally Invasive Gynecology. 23(5). 825–832. 4 indexed citations

11.

Nickers, P., Emmanuelle Tresch, B. Castelain, et al.. (2015). Safety of adjuvant intensity-modulated postoperative radiation therapy in endometrial cancer: Clinical data and dosimetric parameters according to the International Commission on Radiation Units (ICRU) 83 report. Reports of Practical Oncology & Radiotherapy. 20(5). 385–392. 3 indexed citations

12.

Cottu, Paul, Antoîne Italiano, Andréa Varga, et al.. (2015). Onapristone (ONA) in progesterone receptor (PR)-expressing tumors: Efficacy and biomarker results of a dose-escalation phase 1 study.. Journal of Clinical Oncology. 33(15_suppl). 5593–5593. 2 indexed citations

13.

Selle, Frédèric, Emmanuel Sevin, Isabelle Ray‐Coquard, et al.. (2014). A phase II study of lenalidomide in platinum-sensitive recurrent ovarian carcinoma. Annals of Oncology. 25(11). 2191–2196. 8 indexed citations

14.

Castelain, B., S. Taïeb, Pierre Collinet, et al.. (2011). Cancer du col utérin invasif et grossesse : cinq cas observés à Lille de 2002 à 2009. Évaluation des pratiques en référence aux recommandations françaises. Journal de gynécologie, obstétrique et biologie de la reproduction. Supplément. 40(6). 514–521. 5 indexed citations

15.

Leblanc, Éric, Fabrice Narducci, L. Boulanger, et al.. (2009). Chirurgie sus-mésocolique des cancers de l'ovaire: techniques et résultats. Bulletin du Cancer. 96(12). 1199–1205. 3 indexed citations

16.

Taïeb, S., et al.. (2009). IRM fonctionnelle : nouvel outil pour prédire la réponse des cancers du col utérin à la chimioradiothérapie concomitante ?. Cancer/Radiothérapie. 13(6-7). 511–514. 3 indexed citations

17.

Taïeb, S., et al.. (2006). Présentation inhabituelle d'un choriocarcinome gestationnel. Gynécologie Obstétrique & Fertilité. 34(9). 716–719. 4 indexed citations

18.

Leblanc, Éric, Denis Querleu, Fabrice Narducci, et al.. (2000). Surgical staging of early invasive epithelial ovarian tumors. Seminars in Surgical Oncology. 19(1). 36–41. 37 indexed citations

19.

Leblanc, Éric, Denis Querleu, B. Castelain, et al.. (2000). Rôle de la cœliochirurgie dans la prise en charge des cancers du col utérin. Cancer/Radiothérapie. 4(2). 113–121. 8 indexed citations

20.

Peyrat, Jean‐Philippe, Jacques Bonneterre, B. Vandewalle, et al.. (1986). Prolactin Receptors and Lactalbumin Plasma Production in Human Breast Cancer. Annals of the New York Academy of Sciences. 464(1). 427–430. 4 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact